WO2017017301A1
|
|
Crystalline forms of bilastine and preparation methods thereof
|
EP3231796A1
|
|
A process for the preparation of pyrvinium pamoate and crystalline forms thereof
|
ES2607639A1
|
|
Maleic acid salt of a silodosin intermediate
|
EP3101010A1
|
|
New method for the preparation of highly pure ivabradine base and salts thereof
|
EP2641905A1
|
|
Solid forms of strontium ranelate and processes for their preparation
|
EP2589594A1
|
|
Ivabradine hydrochloride Form IV
|
ES2386173A1
|
|
Preparation process of an endotheline receiver antagonist
|
EP1908758A1
|
|
Process for the preparation of (Z)-[11-(3-dimethylamino-propyliden)-6,11-dihydro-dibenzo[b,e]oxepin-2-yl]-acetic acid hydrochloride
|
ES2253996A1
|
|
PROCEDURE FOR THE PREPARATION OF ACID 11 - ((Z) -3- (DIMETHYLAMINE) PROPILIDEN) -6,11-DIHYDRODIBENZ (B, E) OXEPINACETIC.
|
ES2237307A1
|
|
PROCEDURE FOR THE PREPARATION OF ROPINIROL.
|
ES2143408A1
|
|
Promoter and constructions for the expression of recombinant proteins in filamental fungi.
|
ES2109893A1
|
|
Industrial preparation procedure through phosphorilation with phosphorus pentoxide.
|
ES2080689A1
|
|
Procedure for obtaining a protein natural sweetener.
|
ES8606314A3
|
|
Di:hydro benzothiazine di:oxide carboxylic acid deriv. prepn.
|
ES8606307A1
|
|
Prepn. of mono:oxolamine pamoate
|